Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 1;27(1):123-133.
doi: 10.1093/ibd/izaa055.

Optimizing Immunization Strategies in Patients with IBD

Freddy Caldera  1 , Dana Ley  2 , Mary S Hayney  3 , Francis A Farraye  4
Affiliations
Review

Optimizing Immunization Strategies in Patients with IBD

Freddy Caldera et al. Inflamm Bowel Dis. .

Erratum in

Abstract

Recent advances in the treatment of inflammatory bowel disease (IBD) include the use of immune modifiers and monoclonal antibodies, such as tumor necrosis factor (TNF) alpha inhibitors, anti-integrin agents, janus kinase inhibitors, and interleukin-12/23 inhibitors. These agents achieve higher rates of clinical remission and mucosal healing than conventional therapy. However, these therapies increase the risk of infections, including some vaccine-preventable diseases. Infections are one of the most common adverse event of immunosuppressive therapy. Thus, providers should optimize immunization strategies to reduce the risk of vaccine-preventable infections in patients with IBD. There are several newly licensed vaccines recommended for adults by the US Advisory Committee on Immunization Practices. This review will focus on how gastroenterology providers can implement the adult immunization schedule approved by ACIP for patients with IBD.

Keywords: Crohn’s disease; preventive care; serious infections; ulcerative colitis; vaccination; vaccines.

PubMed Disclaimer

MeSH terms